DNA and RNA sequencing revealed a complex intergenic-ALK fusion in a lung adenocarcinoma patient who responded to TKI therapy

Lung Cancer. 2021 Sep:159:171-174. doi: 10.1016/j.lungcan.2021.06.005. Epub 2021 Jun 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma of Lung* / diagnosis
  • Adenocarcinoma of Lung* / drug therapy
  • Adenocarcinoma of Lung* / genetics
  • Anaplastic Lymphoma Kinase / genetics
  • DNA
  • Humans
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / genetics
  • Oncogene Proteins, Fusion / genetics
  • Protein Kinase Inhibitors / therapeutic use
  • Sequence Analysis, RNA

Substances

  • Oncogene Proteins, Fusion
  • Protein Kinase Inhibitors
  • DNA
  • Anaplastic Lymphoma Kinase

Associated data

  • ChiCTR/ChiCTR2000030498